Comparative assessment of different doses of midazolam to prevent etomidate-induced myoclonus – A randomized, double-blind, placebo-controlled trial
Background: Etomidate is a popular induction agent, due to its several advantages for example, an extremely stable hemodynamic profile with no effects on sympathetic nervous system and baroreceptors, minimal effect on respiration and also prevents histamine release in healthy patients or in those w...
Main Authors: | Lokman Manish, Michell Gulabani, Medha Mohta, Geetanjali T Chilkoti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | The Indian Anaesthetists' Forum |
Subjects: | |
Online Access: | http://www.theiaforum.org/article.asp?issn=2589-7934;year=2023;volume=24;issue=1;spage=29;epage=35;aulast=Manish |
Similar Items
-
Comparing the Effect of Sodium Thiopental, Magnesium Sulfate, Midazolam, Prime Etomidate, and Remifentanil on Myoclonus Incidence and Pain Induced by Anesthesia with Etomidate
by: Mohammadreza Safavi, et al.
Published: (2018-01-01) -
Comparison of pretreatment with dexmedetomidine with midazolam for prevention of etomidate-induced myoclonus and attenuation of stress response at intubation: A randomized controlled study
by: Swarnendu Dey, et al.
Published: (2018-01-01) -
Comparative study of midazolam and fentanyl for the prevention of etomidate-induced myoclonus
by: Sophiya Rasool, et al.
Published: (2023-02-01) -
Comparative assessment of dexmedetomidine and butorphanol for attenuation of etomidate-induced myoclonus: A double-blind, randomised controlled study
by: Rajesh S Rautela, et al.
Published: (2023-01-01) -
Comparative study evaluating efficacy of sufentanil versus midazolam in preventing myoclonic movements following etomidate
by: Mohammad Alipour, et al.
Published: (2016-01-01)